Remove news
article thumbnail

'Misinformation': AstraZeneca's China head refutes news report about potential spinoff

Fierce Pharma

But the company is hitting back at the recent news report. . | The largest multinational pharma company in China has reportedly made plans to separate its local business in case geopolitical tensions worsen.

Pharma 303
article thumbnail

'The Top Line': News from ASCO's annual meeting, plus this week's headlines

Fierce Pharma

In this episode of the "The Top Line," we talk with Fierce’s Gabrielle Masson and Andrea Park about the most important news coming from this year's annual ASCO meeting.

210
210
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Nearing FDA approval anniversary, Phathom gets more bad news on Voquezna impurities

Fierce Pharma

Nearing FDA approval anniversary, Phathom gets more bad news on Voquezna impurities fkansteiner Fri, 02/10/2023 - 08:45

FDA 245
article thumbnail

From “Fake News” to “News You Can Use”

PM360

The majority of media believe their role is to be equally balanced between news and entertainment, but only one-third of consumers agree with this. The good news? Almost 90% of consumers want “news,” period. Media and consumers also fail to see eye to eye on the role of media in today’s society.

Media 98
article thumbnail

The Recruiting Crossword Puzzle

The good news? You can solve your recruiting problems using new tools and data specifically designed to help do your job: find top passive talent and fill those open reqs – faster than you thought possible.

article thumbnail

With good news on Lybalvi, Alkermes sees 10% share price increase

Fierce Pharma

As stripped down and divested Alkermes enters 2024 as a “pure-play neuroscience company”—as described by CEO Richard Pops on a conference call on Thursday—much will depend on the success of new sch | As Alkermes enters 2024 as a “pure-play neuroscience company”—as described by CEO Richard Pops on a conference call on Thursday—much will depend on the (..)

Sales 265
article thumbnail

'The Top Line': News from BIO's annual conference, plus this week's headlines

Fierce Pharma

In this episode of "The Top Line," we talk with Fierce’s Max Bayer and Angus Liu about the most important news coming from this year's annual BIO conference.

FDA 130